Troy Asset Management’s Medtronic MDT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-825,095
| Closed | -$65.9M | – | 36 |
|
|
2024
Q4 | $65.9M | Sell |
825,095
-136,104
| -14% | -$11.8M | 2.17% | 13 |
|
|
2024
Q3 | $86.5M | Sell |
961,199
-124,303
| -11% | -$10.5M | 2.73% | 12 |
|
|
2024
Q2 | $85.4M | Sell |
1,085,502
-183,090
| -14% | -$15M | 2.78% | 11 |
|
|
2024
Q1 | $111M | Sell |
1,268,592
-50,594
| -4% | -$4.32M | 3.34% | 10 |
|
|
2023
Q4 | $109M | Sell |
1,319,186
-67,510
| -5% | -$5.15M | 3.44% | 10 |
|
|
2023
Q3 | $109M | Sell |
1,386,696
-86,544
| -6% | -$7.24M | 3.42% | 11 |
|
|
2023
Q2 | $130M | Buy |
1,473,240
+23,373
| +2% | +$2.01M | 3.8% | 10 |
|
|
2023
Q1 | $117M | Sell |
1,449,867
-138,860
| -9% | -$11.3M | 3.46% | 11 |
|
|
2022
Q4 | $123M | Buy |
1,588,727
+168,704
| +12% | +$13.7M | 3.46% | 11 |
|
|
2022
Q3 | $115M | Sell |
1,420,023
-2,937,069
| -67% | -$264M | 3.3% | 11 |
|
|
2022
Q2 | $391M | Sell |
4,357,092
-83,725
| -2% | -$8.48M | 8.04% | 4 |
|
|
2022
Q1 | $493M | Sell |
4,440,817
-137,631
| -3% | -$14.5M | 8.78% | 4 |
|
|
2021
Q4 | $474M | Buy |
4,578,448
+51,714
| +1% | +$5.99M | 8.28% | 4 |
|
|
2021
Q3 | $567M | Sell |
4,526,734
-4,938
| -0.1% | -$639K | 10.72% | 3 |
|
|
2021
Q2 | $563M | Sell |
4,531,672
-134,770
| -3% | -$16.9M | 9.6% | 4 |
|
|
2021
Q1 | $551M | Sell |
4,666,442
-135,117
| -3% | -$15.8M | 10.38% | 2 |
|
|
2020
Q4 | $562M | Buy |
4,801,559
+565,038
| +13% | +$62.2M | 11.46% | 2 |
|
|
2020
Q3 | $440M | Buy |
4,236,521
+391,328
| +10% | +$39.3M | 10.67% | 2 |
|
|
2020
Q2 | $353M | Buy |
3,845,193
+710,351
| +23% | +$68.1M | 9.89% | 3 |
|
|
2020
Q1 | $283M | Buy |
3,134,842
+1,970,839
| +169% | +$210M | 9.27% | 3 |
|
|
2019
Q4 | $132M | Buy |
1,164,003
+8,100
| +0.7% | +$889K | 4.8% | 9 |
|
|
2019
Q3 | $126M | Buy |
1,155,903
+9,900
| +0.9% | +$1.03M | 5.05% | 9 |
|
|
2019
Q2 | $112M | Buy |
1,146,003
+836,400
| +270% | +$76.4M | 4.67% | 8 |
|
|
2019
Q1 | $28.2M | Buy |
309,603
+35,100
| +13% | +$3.14M | 1.38% | 10 |
|
|
2018
Q4 | $25M | Hold |
274,503
| – | – | 1.25% | 11 |
|
|
2018
Q3 | $27M | Sell |
274,503
-2,500
| -0.9% | -$231K | 1.27% | 11 |
|
|
2018
Q2 | $23.7M | Buy |
277,003
+7,643
| +3% | +$638K | 1.22% | 11 |
|
|
2018
Q1 | $21.6M | Buy |
269,360
+13,628
| +5% | +$1.12M | 1% | 13 |
|
|
2017
Q4 | $20.6M | Buy |
255,732
+54,500
| +27% | +$4.36M | 0.85% | 19 |
|
|
2017
Q3 | $15.7M | Buy |
+201,232
| New | +$16.7M | 0.71% | 19 |
|
|
2016
Q3 | – | Sell |
-127,000
| Closed | -$11M | – | 32 |
|
|
2016
Q2 | $11M | Hold |
127,000
| – | – | 0.59% | 15 |
|
|
2016
Q1 | $9.53M | Hold |
127,000
| – | – | 0.52% | 15 |
|
|
2015
Q4 | $9.77M | Hold |
127,000
| – | – | 0.58% | 15 |
|
|
2015
Q3 | $8.5M | Buy |
127,000
+45,000
| +55% | +$3.31M | 0.52% | 15 |
|
|
2015
Q2 | $6.08M | Hold |
82,000
| – | – | 0.39% | 16 |
|
|
2015
Q1 | $640K | Hold |
82,000
| – | – | 5.71% | 9 |
|
|
2014
Q4 | $5.92M | Buy |
+82,000
| New | +$5.7M | 0.39% | 16 |
|
Other funds holding MDT
Troy Asset Management's MDT Position: Q1 2025 in Review
Troy Asset Management sold out of Medtronic (MDT) in Q1 2025, closing a stake of 825,095 shares — an estimated $65.9M sold.
Troy Asset Management first reported a position in MDT in Q4 2014 and held it in 37 quarters. The position peaked at $567M in Q3 2021. 2,170 funds tracked by Wall St. Rank hold MDT as of Q1 2025.
- Troy Asset Management reported no remaining Medtronic position as of Q1 2025 after selling out during the quarter.
- Troy Asset Management sold 825,095 Medtronic shares in Q1 2025, an estimated $65.9M.
- Troy Asset Management first reported a position in Medtronic in Q4 2014 and held it in 37 quarters.
- Troy Asset Management's Medtronic position peaked at $567M in Q3 2021.
- 2,170 funds tracked by Wall St. Rank held Medtronic as of Q1 2025.
Based on Troy Asset Management's 13F filing for Q1 2025, filed 14 May 2025.